Valuation: PharmaEssentia Corporation

Market Cap 544B 16.93B 14.8B 13.68B 12.64B 23.8B 1,626B 24.23B 163B 63.99B 796B 63.59B 62.19B 2,742B P/E 2026 *
46.1x
P/E 2027 * 33.5x
Enterprise Value 518B 16.11B 14.07B 13.01B 12.02B 22.64B 1,547B 23.05B 155B 60.88B 757B 60.49B 59.16B 2,608B EV / Sales 2026 *
20.6x
EV / Sales 2027 * 14.7x
Free-Float
75.37%
Yield 2026 *
0.08%
Yield 2027 * 0.12%
1 day-4.00%
1 week-10.96%
Current month-0.66%
1 month+40.27%
3 months+107.34%
6 months+152.59%
Current year+183.22%
1 week 1,165
Extreme 1165
1,400
1 month 858.22
Extreme 858.216
1,415.34
Current year 423.7
Extreme 423.6991
1,415.34
1 year 395.61
Extreme 395.6133
1,415.34
3 years 222.58
Extreme 222.5833
1,415.34
5 years 56.05
Extreme 56.052
1,415.34
10 years 43.54
Extreme 43.5418
1,415.34
Manager TitleAgeSince
Chief Executive Officer - 01/01/2003
Director of Finance/CFO - 14/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 01/09/2003
Director/Board Member - -
Director/Board Member - 30/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
-4.00%-10.96%+181.91%+328.17% 15.39B
-0.50%-5.60%+56.96%+72.53% 54.49B
+6.05%+7.79%+62.23%+88.46% 55.93B
+0.07%-2.42%+8.07%+434.51% 23.87B
-0.69%-4.13%-18.56%-16.48% 22.86B
+3.51%+10.88%+44.84%-3.21% 20B
+1.92%+0.21%+39.31%-29.41% 17.48B
+7.69%+11.91%+50.03%+720.96% 15.19B
-1.02%-2.30%+22.36%+187.62% 14.02B
-0.31%-1.56%+67.84%+137.79% 12.38B
Average +1.05%-0.33%+51.50%+192.10% 25.16B
Weighted average by Cap. +1.54%+0.38%+50.27%+153.63%

Financials

2026 *2027 *
Net sales 25.07B 780M 682M 630M 582M 1.1B 74.92B 1.12B 7.51B 2.95B 36.68B 2.93B 2.86B 126B 34.57B 1.08B 940M 869M 803M 1.51B 103B 1.54B 10.36B 4.07B 50.58B 4.04B 3.95B 174B
Net income 10.85B 338M 295M 273M 252M 475M 32.44B 483M 3.25B 1.28B 15.88B 1.27B 1.24B 54.69B 14.97B 466M 407M 376M 348M 655M 44.74B 667M 4.49B 1.76B 21.91B 1.75B 1.71B 75.44B
Net Debt -26.52B -825M -721M -667M -616M -1.16B -79.27B -1.18B -7.95B -3.12B -38.81B -3.1B -3.03B -134B -34.73B -1.08B -944M -873M -806M -1.52B -104B -1.55B -10.41B -4.08B -50.82B -4.06B -3.97B -175B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
14/07/26 NT$1,200.00 -4.00% 4,037,292
13/07/26 NT$1,250.00 -2.72% 3,373,173
09/07/26 NT$1,285.00 -6.84% 6,711,957
08/07/26 NT$1,379.28 +2.34% 4,771,223
07/07/26 NT$1,347.72 +3.46% 3,959,953
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1,200.00TWD
Average target price
1,057.48TWD
Spread / Average Target
-11.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock